Corveus Medical
Corveus Medical, founded in 2021 and based in Houston, Texas, is a medical device company dedicated to developing minimally invasive, catheter-based solutions for treating chronic heart failure. Their innovative device targets and deactivates a specific sympathetic nerve branch implicated in heart failure progression, offering new hope to patients with moderate symptoms who have limited treatment options. Key Features and Functionality: - Minimally Invasive Procedure: The catheter-based approach reduces procedural risks and promotes quicker patient recovery compared to traditional surgical methods. - Targeted Nerve Ablation: The device precisely deactivates a specific sympathetic nerve branch associated with heart failure, minimizing collateral tissue damage and enhancing treatment efficacy. - Real-Time Confirmation: During the procedure, physicians can confirm successful nerve deactivation, ensuring the effectiveness and safety of the treatment. Primary Value and Problem Solved: Corveus Medical addresses a significant gap in the treatment of chronic heart failure by providing a novel, minimally invasive option for patients with moderate symptoms who have few existing alternatives. By targeting a root cause of heart failure progression, their device aims to alleviate symptoms, reduce fluid congestion in the heart, and improve overall patient outcomes and quality of life.
Who Is the Company Behind Corveus Medical?
- Seller: Corveus Medical
- HQ Location: Houston, US
-
LinkedIn® Page: www.linkedin.com
1,494 employees on LinkedIn®
